UK pharma: 25 years of innovation and controversy
Whitefriars’ Ketan Patel discusses what investors need to consider when investing in the pharmaceutical sector
Whitefriars’ Ketan Patel discusses what investors need to consider when investing in the pharmaceutical sector
interactive investor identifies the UK stock market’s ‘pandemic philanthropists’ and ‘fallen stars’ amid coronavirus crisis
interactive investor identifies the UK stock market’s ‘pandemic philanthropists’ and ‘fallen stars’ amid coronavirus crisis